Microfluidic precision autostainer for fast multiplexed TSA-based immunofluorescence
13 May 2021
Multiplex immunofluorescence IHC is a powerful technique to address the increasing research needs in immuno-oncology to better understand the tumor microenvironment. This webinar explains how combining rapid microfluidic immunohistochemistry (IHC) with digital pathology can boost your lab's efficiency and yield high-quality results.
About the company
Epredia
Epredia is a global precision cancer diagnostics company working to improve patient outcomes by providing ground-breaking technologies.
Established in July 2019 through an acquisition by PHC Group from Thermo Fisher Scientific, Epredia is powered by some of the most respected names in the industry – Shandon, Richard-Allan Scientific, Microm, Menzel Gläser and others. Together these brands represent the entire histology workflow, from specimen collection to processing, sectioning to staining and advanced imaging to archiving. Visit our website to find a comprehensive offering of workflow solutions for histology, cytology, immunohistochemistry and digital pathology.
Since our humble beginnings in 1937, every product and service developed has been impacted by generations of employees who are committed to improving lives by enabling pathologists and researchers through enhancing precision cancer diagnostics.
Related products
Request Quote for All Products
LabSat® Research
EprediaIntroducing LabSat® Research by Lunaphore, a flexible IHC/IF staining solution for the research lab
